Common Contracts
3 similar null contracts by Horizon Pharma, Inc., Novavax Inc
JPMorgan Chase Bank, National Association London Branch Canary Wharf London E14 5JP EnglandNovavax Inc • January 29th, 2016 • Biological products, (no disgnostic substances) • New York
The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the call option transaction entered into between JPMorgan Chase Bank, National Association, London Branch (“Dealer”) and Novavax, Inc. (“Counterparty”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. This Confirmation shall replace any previous agreements and serve as the final documentation for the Transaction.
Deutsche Bank Deutsche Bank AG, London Branch Winchester HouseHorizon Pharma, Inc. • November 25th, 2013 • Pharmaceutical preparations
New York, New York 10167 New York, NY 10020Horizon Pharma, Inc. • November 25th, 2013 • Pharmaceutical preparations
The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the call option transaction entered into between Société Générale (“Dealer”) and Horizon Pharma, Inc. (“Counterparty”) as of the Trade Date specified below (the “Transaction”). Dealer is acting as principal and SG Americas Securities, LLC (“Agent”), its affiliate, is acting as agent for Dealer for the Transaction under this Confirmation. This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. This Confirmation shall replace any previous agreements and serve as the final documentation for the Transaction.
